眼瞼炎(Blepharitis)の治療薬パイプライン動向（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Blepharitis Overview 6
Therapeutics Development 7
Pipeline Products for Blepharitis – Overview 7
Pipeline Products for Blepharitis – Comparative Analysis 8
Blepharitis – Therapeutics under Development by Companies 9
Blepharitis – Pipeline Products Glance 10
Late Stage Products 10
Clinical Stage Products 11
Early Stage Products 12
Unknown Stage Products 13
Blepharitis – Products under Development by Companies 14
Blepharitis – Companies Involved in Therapeutics Development 15
Foamix Pharmaceuticals Ltd. 15
InSite Vision Incorporated 16
Laboratoires Thea S.A. 17
Novaliq GmbH 18
Blepharitis – Therapeutics Assessment 19
Assessment by Monotherapy Products 19
Assessment by Combination Products 20
Assessment by Target 21
Assessment by Mechanism of Action 23
Assessment by Route of Administration 25
Assessment by Molecule Type 27
Drug Profiles 28
(azithromycin + dexamethasone) – Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
azithromycin – Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
dexamethasone – Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
ISV-405 – Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
minocycline Gel – Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Nov-137 – Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Blepharitis – Recent Pipeline Updates 35
Blepharitis – Dormant Projects 37
Blepharitis – Product Development Milestones 38
Featured News & Press Releases 38
Jul 08, 2014: InSite Vision Plans to Submit New Drug Application to FDA for DexaSite™ for the Treatment of Blepharitis in Adults 38
Jul 23, 2013: InSite Vision Announces Top-line Results from the DOUBle Phase 3 Clinical Study for the Treatment of Moderate-to-Severe Blepharitis 39
Mar 25, 2013: InSite Vision Completes DOUBle Phase III Clinical Study Of AzaSite Plus And DexaSite For Treatment Of Blepharitis 39
Sep 07, 2012: InSite Vision Fully Enrolls Phase III DOUBle Clinical Study Of AzaSite Plus And DexaSite For Blepharitis 41
May 25, 2011: InSite Vision Receives SPA From FDA For DOUBle Phase III Clinical Trial Of AzaSite Plus And DexaSite 42
Apr 14, 2011: InSite Vision Updates Special Protocol Assessment Submission To FDA For Phase III Trial Of AzaSite Plus And DexaSite 43
Apr 26, 2010: Foamix is granted a fourth U.S. patent for OilGel, directed to pharmaceutical compositions and their dermatological, gynecological and ophthalmic applications 44
Appendix 45
Methodology 45
Coverage 45
Secondary Research 45
Primary Research 45
Expert Panel Validation 45
Contact Us 46
Disclaimer 46